Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Apr 4;23(3):325–326. doi: 10.1016/0306-9877(87)90024-7

Was a neurovirulent influenza virus the cause of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam?

CP Maurizi 1
PMCID: PMC7130497  PMID: 3614022

The content is available as a PDF (182.3 KB).

References

  • 1.Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology. 1985;35:193–198. doi: 10.1212/wnl.35.2.193. [DOI] [PubMed] [Google Scholar]
  • 2.O'Brien SJ, Roelke ME, Marker L. Genetic basis for species vulnerability in the cheetah. Science. 1985;227:1428–1434. doi: 10.1126/science.2983425. [DOI] [PubMed] [Google Scholar]
  • 3.Maurizi CP. Why was the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med Hypotheses. 1985;16:1–5. doi: 10.1016/0306-9877(85)90034-9. [DOI] [PubMed] [Google Scholar]
  • 4.Elizan TS, Terasaki PI, Yahr MD. HLA-B14 antigen and postencephalitic Parkinson's disease. Arch Neurol. 1980;37:542–544. doi: 10.1001/archneur.1980.00500580038004. [DOI] [PubMed] [Google Scholar]
  • 5.Poskanzer DC, Schwab RS. Cohort analysis of Parkinson's syndrome. J Chronic Dis. 1963;16:961–973. doi: 10.1016/0021-9681(63)90098-5. [DOI] [PubMed] [Google Scholar]

Articles from Medical Hypotheses are provided here courtesy of Elsevier

RESOURCES